Drug Chatter -- Tracking biopharma stock chatter

Profile for ChemoCentryx, Inc. (CCXI)

« Back to company index

CCXI Chatter Timeline

Stock Ticker for CCXI

Most Active Tweeters for CCXI

UserTweets
@TickerReport 6
@ConsumerFeed 5
@intercooleronli 4
@TheMarketsDaily 4
@WeekHerald 4

Recent Tweets for CCXI

SPNewsAnalysis @SPNewsAnalysis
ChemoCentryx, Inc. $CCXI Cut to “Hold” at Zacks Investment Research https://t.co/cMk3O0hfBk
November 16th 2017, 10:11am
storminvestor @storminvestor
ChemoCentryx, Inc. $CCXI Cut to “Hold” at Zacks Investment Research https://t.co/jjVfKTgNoN
November 16th 2017, 10:11am
ConsumerFeed @ConsumerFeed
ChemoCentryx, Inc. $CCXI Rating Lowered to Hold at Zacks Investment Research https://t.co/bREiU4vw5j
November 15th 2017, 9:11am
dakotafinancial @dakotafinancial
ChemoCentryx, Inc. $CCXI Rating Lowered to Hold at Zacks Investment Research https://t.co/FZAzzQIUjB
November 15th 2017, 9:11am
ZolmaxNews @ZolmaxNews
ChemoCentryx, Inc. $CCXI Shares Bought by Teachers Advisors LLC https://t.co/BmmTObcpAS
November 15th 2017, 5:11am
WKRBNews @WKRBNews
ChemoCentryx, Inc. $CCXI Stock Rating Upgraded by Zacks Investment Research https://t.co/EyicTcRYGC
November 14th 2017, 12:11pm
dailymailtimes @dailymailtimes
ChemoCentryx, Inc. $CCXI Stock Rating Upgraded by Zacks Investment Research https://t.co/euW4ON3v1N
November 14th 2017, 12:11pm
midetimes @midetimes
ChemoCentryx, Inc. $CCXI Stock Rating Upgraded by Zacks Investment Research https://t.co/KfZ8jRoxJ0
November 14th 2017, 12:11pm
dailypoliticaln @dailypoliticaln
ChemoCentryx, Inc. $CCXI Stock Rating Upgraded by Zacks Investment Research https://t.co/tgvXP8R9j8
November 14th 2017, 12:11pm
emq_news @emq_news
ChemoCentryx, Inc. $CCXI Stock Rating Lowered by ValuEngine https://t.co/yvRfQOSwcI
November 14th 2017, 6:11am
TickerReport @TickerReport
ChemoCentryx, Inc. $CCXI Stock Rating Lowered by ValuEngine https://t.co/WCFZmpZNub
November 14th 2017, 6:11am
TickerReport @TickerReport
ChemoCentryx, Inc. $CCXI Stock Rating Lowered by ValuEngine https://t.co/wlhS9KHdg4
November 14th 2017, 6:11am
stocknewstimes @stocknewstimes
Somewhat Favorable Press Coverage Somewhat Unlikely to Impact ChemoCentryx $CCXI Share Price https://t.co/7aPxFtYPA5
November 13th 2017, 7:11pm
SleekMoneycom @SleekMoneycom
Somewhat Favorable Press Coverage Somewhat Unlikely to Impact ChemoCentryx $CCXI Share Price https://t.co/NCgKbiIZN7
November 13th 2017, 7:11pm
dakotafinancial @dakotafinancial
Somewhat Favorable Press Coverage Somewhat Unlikely to Impact ChemoCentryx $CCXI Share Price https://t.co/oA57963Vkt
November 13th 2017, 6:11pm
AmericanBanking @AmericanBanking
Zacks Investment Research Lowers ChemoCentryx, Inc. $CCXI to Hold https://t.co/j1GtWckxSz
November 13th 2017, 6:11pm
CFinancialNews @CFinancialNews
Zacks Investment Research Lowers ChemoCentryx, Inc. $CCXI to Hold https://t.co/i2FE6CaMdt
November 13th 2017, 6:11pm
WeekHerald @WeekHerald
ChemoCentryx, Inc. $CCXI Downgraded by Zacks Investment Research to Hold https://t.co/lG7CZCRWjv
November 13th 2017, 6:11pm
intercooleronli @intercooleronli
Zacks Investment Research Lowers ChemoCentryx, Inc. $CCXI to Hold https://t.co/XfKdmCCkmD
November 13th 2017, 6:11pm
midetimes @midetimes
ChemoCentryx, Inc. $CCXI Downgraded by Zacks Investment Research to Hold https://t.co/UXns63XtgI
November 13th 2017, 5:11pm
dailypoliticaln @dailypoliticaln
ChemoCentryx, Inc. $CCXI Downgraded by Zacks Investment Research to Hold https://t.co/TaNuMoERPg
November 13th 2017, 5:11pm
WKRBNews @WKRBNews
ChemoCentryx, Inc. $CCXI Downgraded by Zacks Investment Research to Hold https://t.co/0IBDjJGWIm
November 13th 2017, 5:11pm
dailymailtimes @dailymailtimes
ChemoCentryx, Inc. $CCXI Downgraded by Zacks Investment Research to Hold https://t.co/5DNMIGNJes
November 13th 2017, 5:11pm
ConsumerFeed @ConsumerFeed
ChemoCentryx downgraded by Zacks Investment Research to hold. https://t.co/zg4chkIjst $CCXI #CCXI
November 13th 2017, 5:11pm
RatingsNetwork @RatingsNetwork
ChemoCentryx downgraded by Zacks Investment Research to hold. https://t.co/LwaPlAeEjn $CCXI #CCXI
November 13th 2017, 5:11pm
ZolmaxNews @ZolmaxNews
ChemoCentryx, Inc. $CCXI Raised to Buy at Zacks Investment Research https://t.co/dZcI4dTXfO
November 13th 2017, 11:11am
TheMarketsDaily @TheMarketsDaily
ChemoCentryx, Inc. $CCXI Rating Increased to Buy at Zacks Investment Research https://t.co/yibNFnDW0Z
November 13th 2017, 10:11am
emq_news @emq_news
Opiant Pharmaceuticals $OPNT vs. ChemoCentryx $CCXI Head to Head Survey https://t.co/Lz9XPN2r7X
November 13th 2017, 9:11am
TickerReport @TickerReport
Opiant Pharmaceuticals $OPNT vs. ChemoCentryx $CCXI Head to Head Survey https://t.co/ponvV3OUJL
November 13th 2017, 9:11am
TickerReport @TickerReport
Opiant Pharmaceuticals $OPNT vs. ChemoCentryx $CCXI Head to Head Survey https://t.co/t9nECUI4RU
November 13th 2017, 9:11am
ledgerzette @ledgerzette
Schwab Charles Investment Management Inc. Raises Holdings in ChemoCentryx, Inc. $CCXI https://t.co/hLpLfeOXmU
November 13th 2017, 8:11am
dispatchtribune @dispatchtribune
ChemoCentryx, Inc. $CCXI Upgraded to “Buy” at Zacks Investment Research https://t.co/HlkqJJ0Hc1
November 13th 2017, 7:11am
TheMarketsDaily @TheMarketsDaily
Public Employees Retirement System of Ohio Has $652,000 Stake in ChemoCentryx, Inc. $CCXI https://t.co/cQFGxBcYbm
November 12th 2017, 8:11am
intercooleronli @intercooleronli
ChemoCentryx, Inc. $CCXI Stock Rating Upgraded by Zacks Investment Research https://t.co/8UWWQ6DLdC
November 11th 2017, 9:11pm
ConsumerFeed @ConsumerFeed
ChemoCentryx, Inc. $CCXI Stock Rating Upgraded by Zacks Investment Research https://t.co/KetYxUEzKG #acn
November 11th 2017, 9:11pm
CFinancialNews @CFinancialNews
ChemoCentryx, Inc. $CCXI Stock Rating Upgraded by Zacks Investment Research https://t.co/zIVVeOqWsE
November 11th 2017, 9:11pm
AmericanBanking @AmericanBanking
ChemoCentryx, Inc. $CCXI Stock Rating Upgraded by Zacks Investment Research https://t.co/Aztw6vvpkZ
November 11th 2017, 9:11pm
AmericanBanking @AmericanBanking
ChemoCentryx, Inc. $CCXI Downgraded by ValuEngine https://t.co/W7KvMUuMg8
November 11th 2017, 7:11pm
CFinancialNews @CFinancialNews
ChemoCentryx, Inc. $CCXI Downgraded by ValuEngine https://t.co/Zv1MxPWvRC
November 11th 2017, 7:11pm
ConsumerFeed @ConsumerFeed
ChemoCentryx, Inc. $CCXI Downgraded by ValuEngine https://t.co/A9dSyswOcn #acn
November 11th 2017, 7:11pm
intercooleronli @intercooleronli
ChemoCentryx, Inc. $CCXI Downgraded by ValuEngine https://t.co/jZ9OQifN1n
November 11th 2017, 7:11pm
SleekMoneycom @SleekMoneycom
Head-To-Head Analysis: ChemoCentryx $CCXI vs. Opiant Pharmaceuticals $OPNT https://t.co/DHbGiOuoDW
November 11th 2017, 7:11am
stocknewstimes @stocknewstimes
Head-To-Head Analysis: ChemoCentryx $CCXI vs. Opiant Pharmaceuticals $OPNT https://t.co/cTokmjGqn3
November 11th 2017, 7:11am
dailymailtimes @dailymailtimes
Head-To-Head Analysis: ChemoCentryx $CCXI vs. Opiant Pharmaceuticals $OPNT https://t.co/kotAhEAomD
November 11th 2017, 3:11am
dailypoliticaln @dailypoliticaln
Head-To-Head Analysis: ChemoCentryx $CCXI vs. Opiant Pharmaceuticals $OPNT https://t.co/mUwS0GPqbL
November 11th 2017, 3:11am
WKRBNews @WKRBNews
Head-To-Head Analysis: ChemoCentryx $CCXI vs. Opiant Pharmaceuticals $OPNT https://t.co/hXA4sJXSKg
November 11th 2017, 3:11am
midetimes @midetimes
Head-To-Head Analysis: ChemoCentryx $CCXI vs. Opiant Pharmaceuticals $OPNT https://t.co/2qVV8Y3PVO
November 11th 2017, 2:11am
TheMarketsDaily @TheMarketsDaily
ChemoCentryx, Inc. $CCXI Downgraded by ValuEngine to Sell https://t.co/pmPLZPJ0HZ
November 10th 2017, 10:11pm
SleekMoneycom @SleekMoneycom
ChemoCentryx, Inc. $CCXI Lifted to Buy at Zacks Investment Research https://t.co/f1Yr1CcPD2
November 10th 2017, 5:11pm
WatchlistN @WatchlistN
ChemoCentryx, Inc. $CCXI Lifted to Buy at Zacks Investment Research https://t.co/uxrYj9XlLH
November 10th 2017, 5:11pm

Contact © thinkBiotech LLC 2004 - 2017. All rights reserved.